News | December 05, 2023
AstraZeneca discontinues Phase III trials of Stabilizer-CKD and Dialize-Outcomes
STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme
STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India
These regulatory approvals signify a significant milestone for Venus Remedies Limited
Currently, Venkat is Lead – Market Access, India at Pfizer
Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of US $33 million in the US
The product has been in-licensed from Strides and will be commercialized by Amneal
The product is expected to be launched in FY25
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Subscribe To Our Newsletter & Stay Updated
